tiprankstipranks
Dhanuka Agritech Limited (IN:DHANUKA)
:DHANUKA
India Market
Want to see IN:DHANUKA full AI Analyst Report?

Dhanuka Agritech Limited (DHANUKA) AI Stock Analysis

3 Followers

Top Page

IN:DHANUKA

Dhanuka Agritech Limited

(DHANUKA)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
₹1,272.00
▲(14.15% Upside)
Action:Upgraded
Date:05/21/26
The score is primarily driven by strong financial quality (notably the very low leverage balance sheet and solid profitability) but is held back by historically uneven cash-flow conversion and a richer valuation (high P/E with low dividend yield). Technicals are supportive in the medium term, though near-term momentum appears somewhat stretched.
Positive Factors
Conservative balance sheet
Extremely low leverage materially lowers financial risk and preserves flexibility across cycles. A conservative balance sheet supports funding for distribution, product launches, and working-capital needs without heavy external financing, enabling durable resilience to agricultural seasonality and input shocks.
Negative Factors
Uneven cash conversion
Persistent gaps between reported earnings and operating cash highlight working-capital and timing risks. If receivables or inventory build repeat cyclically, the company may face pressure on liquidity or need external financing, limiting reinvestment or strategic flexibility during weaker seasons.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Extremely low leverage materially lowers financial risk and preserves flexibility across cycles. A conservative balance sheet supports funding for distribution, product launches, and working-capital needs without heavy external financing, enabling durable resilience to agricultural seasonality and input shocks.
Read all positive factors

Dhanuka Agritech Limited (DHANUKA) vs. iShares MSCI India ETF (INDA)

Dhanuka Agritech Limited Business Overview & Revenue Model

Company Description
Dhanuka Agritech Limited manufactures and sells a range of agro-chemicals in India. It offers herbicides, insecticides, fungicides, and plant growth regulators in various forms, such as liquid, dust, powder, and granules. The company also generate...
How the Company Makes Money
Dhanuka Agritech makes money primarily by selling branded agrochemical formulations used for crop protection and yield improvement. Its core revenue stream is domestic sales of crop protection products—mainly insecticides, herbicides, fungicides, ...

Dhanuka Agritech Limited Financial Statement Overview

Summary
Strong overall fundamentals supported by a very conservative balance sheet (very low leverage) and solid profitability with accelerating revenue growth into FY2026. The main constraint is earnings quality consistency: operating cash conversion has been uneven historically despite a strong FY2026 free-cash-flow rebound, and margins show volatility.
Income Statement
78
Positive
Balance Sheet
92
Very Positive
Cash Flow
63
Positive
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue20.14B20.20B20.35B17.33B17.00B14.63B
Gross Profit7.49B5.59B8.16B6.59B5.85B5.23B
EBITDA4.23B4.03B4.17B3.62B3.23B2.97B
Net Income2.80B2.87B2.97B2.39B2.34B2.09B
Balance Sheet
Total Assets20.29B21.02B18.00B15.79B14.05B13.12B
Cash, Cash Equivalents and Short-Term Investments1.35B2.97B1.24B723.49M992.53M1.98B
Total Debt318.38M306.39M742.33M269.79M335.17M318.07M
Total Liabilities4.86B4.20B3.97B3.23B3.44B3.52B
Stockholders Equity15.43B16.82B14.03B12.56B10.61B9.60B
Cash Flow
Free Cash Flow255.12M1.82B686.61M451.24M120.50M444.51M
Operating Cash Flow398.19M2.09B2.63B1.34B1.36B1.04B
Investing Cash Flow191.17M-1.35B-1.43B-808.93M25.65M-426.01M
Financing Cash Flow-554.26M-560.78M-1.20B-565.42M-1.37B-608.00M

Dhanuka Agritech Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1114.30
Price Trends
50DMA
1021.88
Positive
100DMA
1067.57
Positive
200DMA
1261.68
Negative
Market Momentum
MACD
26.18
Negative
RSI
64.67
Neutral
STOCH
59.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DHANUKA, the sentiment is Positive. The current price of 1114.3 is above the 20-day moving average (MA) of 1082.18, above the 50-day MA of 1021.88, and below the 200-day MA of 1261.68, indicating a neutral trend. The MACD of 26.18 indicates Negative momentum. The RSI at 64.67 is Neutral, neither overbought nor oversold. The STOCH value of 59.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:DHANUKA.

Dhanuka Agritech Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
₹80.41B11.531.02%21.94%123.70%
71
Outperform
₹52.49B33.240.17%-0.75%-2.74%
64
Neutral
₹48.27B-69.070.92%8.79%46.91%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
₹23.13B23.160.02%5.46%-27.45%
56
Neutral
₹19.16B21.940.43%33.50%77.45%
49
Neutral
₹7.58B-10.640.39%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:DHANUKA
Dhanuka Agritech Limited
1,151.55
-473.52
-29.14%
IN:BHARATRAS
Bharat Rasayan Limited
1,391.75
-1,060.73
-43.25%
IN:HERANBA
Heranba Industries Limited
189.45
-89.69
-32.13%
IN:IPL
India Pesticides Ltd.
166.35
-4.59
-2.69%
IN:RALLIS
Rallis India Limited
248.20
-29.77
-10.71%
IN:SHARDACROP
Sharda Cropchem Ltd.
891.30
266.03
42.55%

Dhanuka Agritech Limited Corporate Events

Dhanuka Agritech Launches ₹70 Crore Share Buyback at ₹1,400 Per Share
May 21, 2026
Dhanuka Agritech Limited has announced a buyback offer for up to 500,000 fully paid-up equity shares with a face value of ₹2 each at a price of ₹1,400 per share, payable in cash. The buyback, to be executed on a proportionate basis thr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 21, 2026